Insider Trading & Ownership - Chardonnet Laurent

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Chardonnet Laurent
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-05-23
Purchase
2023-05-25
4:05 pm
Prelude Therapeutics IncPRLDChardonnet Laurent
Chief Financial Officer
5,000$5.5$27,50042,165
(Direct)
View
2022-12-08
Purchase
2022-12-12
09:13 am
Prelude Therapeutics IncPRLDChardonnet Laurent
Chief Financial Officer
10,000$4.76$47,60035,873
(Direct)
View
2022-06-01
Purchase
2022-06-01
4:31 pm
Prelude Therapeutics IncPRLDChardonnet Laurent
Chief Financial Officer
10,000$4.23$42,30024,500
(Direct)
View
2020-01-31
Purchase
2020-01-31
8:44 pm
Axcella Health Inc.AXLAChardonnet Laurent
Chief Financial Officer
3,000$4.94$14,8203,665
(Direct)
View
2020-01-24
Purchase
2020-01-28
6:39 pm
Axcella Health Inc.AXLAChardonnet Laurent
Chief Financial Officer
665$4.9306$3,279665
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-03-01
Option Award
2024-03-04
6:04 pm
N/A
2034-02-28
Prelude Therapeutics IncPRLDChardonnet Laurent
Chief Financial Officer
150,000$0150,000
(Direct)
View
2023-02-07
Option Award
2023-02-09
4:07 pm
N/A
2033-02-06
Prelude Therapeutics IncPRLDChardonnet Laurent
Chief Financial Officer
135,000$0135,000
(Direct)
View
2022-12-21
Option Award
2022-12-22
4:05 pm
N/A
2032-12-20
Prelude Therapeutics IncPRLDChardonnet Laurent
Chief Financial Officer
75,000$075,000
(Direct)
View
2022-03-21
Option Award
2022-03-22
6:01 pm
N/A
N/A
Prelude Therapeutics IncPRLDChardonnet Laurent
Chief Financial Officer
6,500$7.5114,500
(Direct)
View
2022-02-15
Option Award
2022-02-17
7:11 pm
N/A
2032-02-14
Prelude Therapeutics IncPRLDChardonnet Laurent
Chief Financial Officer
90,000$090,000
(Direct)
View
2021-12-13
Option Award
2021-12-14
5:37 pm
N/A
N/A
Prelude Therapeutics IncPRLDChardonnet Laurent
Chief Financial Officer
5,000$12.288,000
(Direct)
View
2021-11-29
Option Award
2021-12-01
6:00 pm
N/A
2031-11-28
Prelude Therapeutics IncPRLDChardonnet Laurent
Chief Financial Officer
180,000$0180,000
(Direct)
View

Ownership
2021-12-01
5:56 pm
N/A
N/A
Prelude Therapeutics IncPRLDChardonnet Laurent
Chief Financial Officer
0$03,000
(Direct)
View
2020-10-30
Option Award
2021-02-11
9:28 pm
N/A
N/A
Axcella Health Inc.AXLAChardonnet Laurent
Chief Financial Officer
2,601$3.6211,266
(Direct)
View
2021-02-09
Option Award
2021-02-11
9:28 pm
N/A
N/A
Axcella Health Inc.AXLAChardonnet Laurent
Chief Financial Officer
205,000$0211,266
(Direct)
View
2019-12-18
Option Award
2019-12-20
8:02 pm
N/A
2029-12-18
Axcella Health Inc.AXLAChardonnet Laurent
Chief Financial Officer
72,500$072,500
(Direct)
View